Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

In brief

Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Key facts

Study ID

NCT07092111

Run by

The First Affiliated Hospital with Nanjing Medical University

People needed

110

Starts

2024-07-01

Expected to finish

2025-09-01

Last updated by the study team

2025-07-29

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients with breast cancer diagnosed with stage I-III;
• Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
• 18 years old≤ age≤ 75 years old, female;
• Subjects voluntarily participate in this trial and sign the informed consent form.

You may not qualify if…

• Patients who have had acupuncture treatment in the past;
• After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
• Platelets< 50,000/μL;
• Patients with CIPN≥1 grade 1 (NCI-CTCAE);
• Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.

Where it is running

• Jiangsu Provincial People's Hospital — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.